4DMedical Renews University of Michigan Medical Center Contract Until June 2028, Shares Jump 4%

MT Newswires Live
2025/07/18

4DMedical (ASX:4DX) said it renewed its contract with the University of Michigan Medical Center for another three years from July 1 to June 30, 2028, for a total value of around AU$155,000, according to a Friday Australian bourse filing.

University of Michigan clinicians and researchers will have access to 4DMedical's full suite of structural lung analysis applications via the Enterprise Core Computing platform.

The firm also reported the award of AU$1.1 million in non-dilutive cash funding under the first round of Australia's Economic Accelerator Innovate grant program for a project led by the University of Adelaide with 4DMedical as one of the partners.

The project will seek to develop AI-derived functional biomarkers to enhance respiratory disease diagnosis and treatment.

Its shares jumped 4% in recent trading on Friday.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10